The Economic Dynamics of Modern Biotechnology

The Economic Dynamics of Modern Biotechnology
Author: Maureen D. McKelvey
Publisher: Edward Elgar Publishing
Total Pages: 438
Release: 2004-01-01
Genre: Business & Economics
ISBN: 9781845420611

'All would agree that with more than 3, 000 new firms formed in Europe, Japan and the United States focused on biotechnology, and with elegant strides forward in our understanding of genetics, the genome, proteomics and other related fields, a true intellectual, social and industrial revolution is in the making. Maureen McKelvey et al provide fascinating data on firm formation, case studies of emerging business models and cross-regional and national comparisons. The work is a useful beginning in our understanding of an emerging phenomenon.' - James M. Utterback, Massachusetts Institute of Technology, US This book offers a novel insight into the economic dynamics of modern biotechnology, using examples from Europe to reflect global trends. The authors apply theoretical insight to a fundamental enigma of the modern learning society, namely, how and why the development of knowledge and ideas interact with market processes and the formation of industries and firms.

The Economic and Social Dynamics of Biotechnology

The Economic and Social Dynamics of Biotechnology
Author: John de la Mothe
Publisher: Springer Science & Business Media
Total Pages: 282
Release: 2012-12-06
Genre: Business & Economics
ISBN: 1461543231

`Biotechnology' - the integrated use of biochemistry, microbiology, and chemical engineering for the technological application of the capabilities of microbes and cultured tissue cells - is quickly becoming pervasive and challenging, rapidly developing both new techniques and industries. The Economic and Social Dynamics of Biotechnology - a joint project between Statistics Canada, the Program of Research on Innovation, Management and Economy (PRIME) at the University of Ottawa, and CIRANO at the University of Quebec in Montreal - brings together economic, social, and statistical views on the dynamics of this set of emerging technologies. It examines the costs as well as the benefits - the challenges as well as the choices - of the rapidly expanding science-based world of biodiversity, biopharmaceuticals, and bioinformatics, and it provides suggestions for future work and research. This project fits into an ongoing research program at Statistics Canada to develop meaningful indicators for science, technology, and innovation in a technology-intensive economy. This book tells the story of the inner workings of innovation systems, technological systems, and competence blocs in the production, use, and diffusion of knowledge.

Economics of Biotechnology

Economics of Biotechnology
Author: T. V. S. Ramamohan Rao
Publisher: New Age International
Total Pages: 21
Release: 2007-12
Genre: Biotechnology
ISBN: 8122420036

Modern biotechnology has come into prominence since 1980. It relates to a set of techniques that involve manipulation or change of the genetic inheritance of living organisms including plants. The primary advantage of this technology is that it can target drugs and pesticides to the exact location of the human body or plants where they are needed.

Biotechnology

Biotechnology
Author: Organisation for Economic Co-operation and Development
Publisher: Organisation for Economic Co-operation and Development ; [Washington, D.C. : OECD Publications and Information Centre
Total Pages: 120
Release: 1989
Genre: Science
ISBN:

Trading in Genes

Trading in Genes
Author: Ricardo Melendez-Ortiz
Publisher: Routledge
Total Pages: 355
Release: 2013-06-17
Genre: Business & Economics
ISBN: 1136551042

Few scientific developments have given rise to as much controversy as biotechnology. Numerous groups are united in their opposition, expressing concern over environmental and health risks, impacts on rural livelihoods, the economic dominance of multinational companies and the ethical implications of crossing species boundaries. Among the supporters of the technology are those that believe in its potential to enhance food security, further economic development, increase productivity and reduce environmental pressures. As a result, countries - and sectors within countries - find themselves at odds with each other while potential opportunities for development offered by the use of biotechnology are seized or missed, and related risks go unmanaged. This book, a unique interdisciplinary collection of perspectives from the developing world, examines the ongoing debate. Writing for the International Centre for Trade and Sustainable Development, leading experts address issues such as diffusion of technology, intellectual property rights, the Cartagena Protocol, impacts of international trade, capacity building and biotechnology research and regulation. With the most recent and relevant examples from around the world, Trading in Genes offers the reader a single-volume overview of the connections between biotechnology, trade and sustainability that is both wide-ranging and thorough

Trading In Genes

Trading In Genes
Author: Ricardo Meléndez-Ortiz
Publisher: Earthscan
Total Pages: 321
Release: 2013
Genre: Business & Economics
ISBN: 1849773432

Few scientific developments have given rise to as much controversy as biotechnology. Numerous groups are united in their opposition, expressing concern over environmental and health risks, impacts on rural livelihoods, the economic dominance of multinational companies and the ethical implications of crossing species boundaries. Among the supporters of the technology are those that believe in its potential to enhance food security, further economic development, increase productivity and reduce environmental pressures. As a result, countries - and sectors within countries - find themselves at odds with each other while potential opportunities for development offered by the use of biotechnology are seized or missed, and related risks go unmanaged. This book, a unique interdisciplinary collection of perspectives from the developing world, examines the ongoing debate. Writing for the International Centre for Trade and Sustainable Development, leading experts address issues such as diffusion of technology, intellectual property rights, the Cartagena Protocol, impacts of international trade, capacity building and biotechnology research and regulation. With the most recent and relevant examples from around the world, Trading in Genes offers the reader a single-volume overview of the connections between biotechnology, trade and sustainability that is both wide-ranging and thorough

Biotechnology and Telecommunications Innovation

Biotechnology and Telecommunications Innovation
Author: Maureen D. McKelvey
Publisher:
Total Pages: 104
Release: 2005-01-01
Genre: Biotechnology
ISBN: 9780975043677

This special issue of Innovation: Management, Policy & Practice (ISBN 0-9750436-7-6) addresses 'Conditions for Innovation in Biotechnology and Telecommunication'. Each article addresses one or both of these emerging technologies as well as aspects of innovation processes, and each thereby contributes to the growing literature on technologies. The editors have worked extensively on modern biotechnology and telecommunication, and therefore we also have broader ambitions beyond the selection of individual papers to be published. Taken as a whole, this special issue aims to contribute towards specifying the similarities and differences during innovation processes in emerging technologies. This piece provides some background information on the editors, the general problems and three themes to be addressed in this special issue, before introducing each subsequent article.This special issue is the result of a longer debate about how and why modern biotechnology, ICT, and telecommunication develop and impact on society, among us and among many other researchers. Both of us, Erik Bohlin and Maureen McKelvey, work at the School of Technology Management & Economics, Chalmers University of Technology, Sweden, where we have the great fortune to have many excellent students and colleagues interested in innovation and interested in these particular technologies. Earlier versions of papers for this special issue were presented at a workshop we organized at Chalmers (May 19-20, 2003) entitled 'Innovations and Entrepreneurship in Biotech/ Pharmaceuticals and in IT/ Telecommunication'.1 Hence, as guest editors, we wish to gratefully acknowledge the financial support from Chalmers to stimulate research and teaching related to management & economic issues in telecom and biotech.One reason for putting together a special issue is that we are convinced that comparing and contrasting conditions for innovation is a crucial issue for researchers, government policy-makers, firm managers and others associated with emerging technologies. To what extent can general principles be identified for this type of innovation process? To what extent can general principles be identified for innovations as drivers of a particular type of economic dynamics? To what extent can each emerging technology be understood as a unique historical case? Deciding about the range of possible policy interventions requires a re-assessment of the extent to which emerging technologies are influenced by general principles, as opposed to the vagrancies of historical circumstances. Our ambition with devoting a special issue to modern biotechnology and telecommunication is to encourage others - and ourselves - to move beyond the details of innovation in specific technologies to strive for more systematic and comprehensive comparisons.

Measuring the Contribution of Modern Biotechnology to the Canadian Economy

Measuring the Contribution of Modern Biotechnology to the Canadian Economy
Author: Ricardo de Avillez
Publisher:
Total Pages: 91
Release: 2011
Genre: Biotechnology
ISBN:

The role of modern biotechnology in agriculture, medicine, and industry has increased dramatically since the 1970s. Despite its growing importance, few efforts have been made so far to estimate the economic contribution of modern biotechnology to the Canadian economy. This report provides an overview of biotechnology activities in Canada, and, using an income-based approach, estimates that biotechnology activities accounted for approximately $15 billion in 2005, equivalent to 1.19 per cent of Canada's GDP in that year. The report also forecasts that the role of biotechnology in the economy will increase substantially in the next twenty years, representing between 2.6 per cent and 6.0 per cent of Canada's GDP in 2030.